Advertisement
Advertisement
Malaysia
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
Gynaecologist John Tang Ing Ching, inventor of the Wondaleaf Unisex Condom. Photo: Twin Catalyst/Handout via Reuters

Malaysian gynaecologist invents ‘world’s first’ unisex condom

  • John Tang Ing Chinh makes the condoms using a material used in transparent wound dressings that is thin and flexible yet strong and waterproof
  • He said he hopes his invention will empower people to take better control of their sexual health regardless of their sex or sexual orientation
Malaysia
A Malaysian gynaecologist has created what he says is the world’s first unisex condom that can be worn by females or males and is made from a medical grade material usually used as a dressing for injuries and wounds.

Its inventor hopes the Wondaleaf Unisex Condom will empower people to take better control of their sexual health regardless of their sex or sexual orientation.

“It’s basically a regular condom with an adhesive covering,” said John Tang Ing Chinh, a gynaecologist at medical supplies firm Twin Catalyst.

A box of Wondaleaf unisex condoms is seen at a factory in Sibu, Malaysia. Photo: Twin Catalyst handout via Reuters

“It’s a condom with an adhesive covering that attaches to the vagina or penis, as well as covering the adjacent area for extra protection,” Tang said.

The adhesive is only applied to one side of the condom, he added, meaning it can be reversed and used by either sex.

Each box of Wondaleaf contains two condoms, and will cost 14.99 ringgit (US$3.61). The average price for a dozen condoms in Malaysia is 20-40 ringgit.

Vietnam busts factory that recycled thousands of used condoms

Tang makes the condoms using polyurethane, a material used in transparent wound dressings that is thin and flexible yet strong and waterproof.

“Once you put it on, you often don’t realise that it’s there,” he said, referring to dressings made from the material.

Tang said the Wondaleaf had gone through several rounds of clinical research and testing and would be available commercially via the company’s website later this year.

“Based on the number of clinical trials we have conducted, I am quite optimistic that given time it will be a meaningful addition to the many contraceptive methods used in the prevention of unintended pregnancies and sexually transmitted diseases,” Tang said.

2